Scientists create the first CRISPR-based drug candidate targeting the microbiome

Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant. For some patients, like those with blood cancer, however, there is a risk that the bacteria will travel into the bloodstream. In those cases, an E. coli infection is too often fatal. The mortality rate is 15-20%.

Leave A Comment

Your email address will not be published. Required fields are marked *